CDC Warns Healthcare Workers of Emerging, Multidrug-Resistant Fungus

May 30, 2017 by Kathleen Wiley RN, MSN, AOCNS®

Candida auris is a multidrug-resistant yeast that is known to cause invasive infection and death. It first emerged in June 2016 and continues to present itself as a serious global threat. According to the Centers for Disease Control and Prevention (CDC), throughout 2017, healthcare facilities in multiple countries report serious illnesses caused by C.auris in hospitalized patients.

The fungi's ability to resist common antifungal agents such as fluconazole, voriconazole, and amphotericin B, as well as its ability to survive on surfaces in healthcare environments and spread between patients, is of great concern to healthcare professionals.

In confirmed U.S. cases, C. auris was cultured and confirmed most commonly among blood and urine samples, the respiratory tract, bile fluids, wounds, and central venous catheters. Environmental testing confirmed presence of the organism on mattresses, windows, chairs, and infusion pumps, among other hard surfaces.

Testing for C. auris his performed through swabbing groin, axilla, and in some cases, the nose, urine or ears; however, in most cases the axilla and groin are the consistent sites of colonization.

Vital Information for Healthcare Providers

The following CDC links are good educational resources for healthcare workers regarding infection control principles, risk factors, and diagnostic and treatment recommendations related to C. auris.


Copyright © 2017 by the Oncology Nursing Society. User has permission to print one copy for personal or unit-based educational use. Contact pubpermissions@ons.org for quantity reprints.